BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Finance Desk//Catalysts//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Finance Desk catalysts
X-PUBLISHED-TTL:PT1H
REFRESH-INTERVAL;VALUE=DURATION:PT1H
BEGIN:VEVENT
UID:fd-catalyst-2701@financedesk
DTSTAMP:20261013T234012Z
DTSTART;VALUE=DATE:20261231
SUMMARY:FDA decision on CagriSema (weight management) (est.)
DESCRIPTION:Estimated date.\nNovo Nordisk\, CagriSema (cagrilintide + sema
 glutide)\, NVO\nhttps://www.wiremeridian.com/c/novo-nordisk
URL:https://www.wiremeridian.com/c/novo-nordisk
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR